Akramul Ansary
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Akramul Ansary has a total of 34 co-authors. Here are the top co-authors by number of shared publications:
- Bhargab Jyoti Sahariah
NETES Institute of Pharmaceutical Science
6 shared publications - Amit Kumar Das
Department of Pharmaceutics, NETES Institute of Pharmaceutical Science, NEMCARE Group of Institutions, Mirza, Assam, 781125, India
3 shared publications - Koushik Nandan Dutta
NETES Institute of Pharmaceutical Science, NEMCARE Group of Institutions
2 shared publications - Manish Majumder
NETES Institute of Pharmaceutical Science
2 shared publications - Manoj Kashyap
Department of Pharmacognosy, School of Pharmacy, Pragjyotishpur University, Hajongbari, Chandrapur, Guwahati, Assam, 781150, India
2 shared publications - Manoj Kumar Deka
Department of Pharmaceutics, NETES Institute of Pharmaceutical Science, NEMCARE Group of Institutions, Mirza, Assam, 781125, India
2 shared publications
Latest Publications
- Open Access
- 12 July 2026
- Published by Springer Nature in Discover Chemistry
- Vol. 3 (1) , 401
Pyridine-based derivatives as emerging scaffolds for immunomodulatory drug development
- 12 July 2026
- Published by Springer Nature in Discover Chemistry
- Vol. 3 (1) , 401
Open AccessPyridine-based derivatives as emerging scaffolds for immunomodulatory drug development
- Open Access
- 14 April 2026
- Published by Elsevier in SSRN Electronic Journal
Nanosponge-Induced Amorphization for Controlled Transdermal Delivery of Febuxostat
Febuxostat is a selective xanthine oxidase inhibitor that is taken to manage gout; it has low aqueous solubility and unpredictable oral bioavailability. This paper examined amorphization induced by nanosponge incorporated in a sodium alginate transdermal system to achieve localized delivery of systems into the body. Emulation-solvent diffusion was used to prepare febuxostat-loaded nanosponges which were optimized with response surface methodology. The optimized formula had a particle size of 245.3 nm and entrapment efficiency of 77. Differential scanning calorimetry established a decrease of melting enthalpy of 92.4 J/g (pure drug) to 24.6 J/g, that is, a reduction of crystallinity by 73.4%. X-ray-diffraction of powdered material indicated a reduction of 66.04 in the amount of the peak at 33.96 crystallinity, which is indicative of amorphization. The patch loading nanosponge exhibited unburst continuous in vitro release (70.58% at 24 h). The release obeyed the first-order kinetics (R 2 = 0.9905) with a Korsmeyerexponent (n = 0.9954), which was anomalous diffusion. Ex vivo permeation analysis revealed steadiest flux of 0.2302, -g/cm 2/min (R 2=0.9986) and permeability coefficient of 0.04426 cm/min. Pharmacokinetic analysis in Wistar rats detected Cmax of 19,761.6ng/mL at Tmax of 24h, elimination half-life of 13.02h, AUC0-infty of 573,383 ng.h/mL, and MRT of 33.77h, which confirms the long systemic exposure. Stability tests showed that there was no major disturbance in the physicochemical whether in the accelerated conditions. These results define a structure-property-performance correlation that shows that solid-state conversion aided by nanosponge with diffusion under controlled by the matrix permits the delivery of poorly soluble drugs over an extended period by transdermal delivery.
- 14 April 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessNanosponge-Induced Amorphization for Controlled Transdermal Delivery of Febuxostat
Febuxostat is a selective xanthine oxidase inhibitor that is taken to manage gout; it has low aqueous solubility and unpredictable oral bioavailability. This paper examined amorphization induced by nanosponge incorporated in a sodium alginate transdermal system to achieve localized delivery of systems into the body. Emulation-solvent diffusion was used to prepare febuxostat-loaded nanosponges which were optimized with response surface methodology. The optimized formula had a particle size of 245.3 nm and entrapment efficiency of 77. Differential scanning calorimetry established a decrease of melting enthalpy of 92.4 J/g (pure drug) to 24.6 J/g, that is, a reduction of crystallinity by 73.4%. X-ray-diffraction of powdered material indicated a reduction of 66.04 in the amount of the peak at 33.96 crystallinity, which is indicative of amorphization. The patch loading nanosponge exhibited unburst continuous in vitro release (70.58% at 24 h). The release obeyed the first-order kinetics (R 2 = 0.9905) with a Korsmeyerexponent (n = 0.9954), which was anomalous diffusion. Ex vivo permeation analysis revealed steadiest flux of 0.2302, -g/cm 2/min (R 2=0.9986) and permeability coefficient of 0.04426 cm/min. Pharmacokinetic analysis in Wistar rats detected Cmax of 19,761.6ng/mL at Tmax of 24h, elimination half-life of 13.02h, AUC0-infty of 573,383 ng.h/mL, and MRT of 33.77h, which confirms the long systemic exposure. Stability tests showed that there was no major disturbance in the physicochemical whether in the accelerated conditions. These results define a structure-property-performance correlation that shows that solid-state conversion aided by nanosponge with diffusion under controlled by the matrix permits the delivery of poorly soluble drugs over an extended period by transdermal delivery.
- 15 November 2025
- Published by Elsevier in Bioprinting
- Vol. 52
Pharmaceutical excipients: Metamorphosis from conventional formulation to 3D printing
- 15 November 2025
- Published by Elsevier in Bioprinting
- Vol. 52
Pharmaceutical excipients: Metamorphosis from conventional formulation to 3D printing
- 26 August 2025
- Published by FABAD Farmasotik Bilimler Ankara Dernegi in Fabad Journal of Pharmaceutical Sciences
- Vol. 50 (2) , 447-480
A Comprehensive Review on The Phytochemical Profile, Ethnobotanical Uses and Pharmacological Activities of Cuscuta Reflexa Roxb.: An Asiatic Parasitic Vine
Cuscuta reflexa Roxb., commonly called dodder, represents a distinctive parasitic plant within the Convolvulaceae family, notable for its remarkable absence of roots and leaves. Beyond its botanical peculiarities, Cuscuta reflexa holds significant medicinal value, featuring prominently in numerous therapeutic formulations esteemed for their efficacy in addressing a diverse spectrum of ailments, including migraines, headaches, constipation, chronic catarrh, epilepsy, prolonged fever, amnesia, and itching, among others. This review endeavors to present a comprehensive synthesis of the botanical, taxonomical, pharmacological, and phytochemical attributes of Cuscuta reflexa. Employing a meticulous literature survey encompassing research articles published between 2010 and 2024, sourced from electronic databases the medicinal potential of Cuscuta reflexa emerges as multifaceted. Approximately 25 bioactive compounds have been identified and isolated from various anatomical components of the plant, showcasing significant pharmacological promise. However, despite the promising findings, a comprehensive understanding of the therapeutic mechanisms underlying Cuscuta reflexa's medicinal attributes necessitates further in vivo pharmacological and toxicological investigations. These endeavors are indispensable for unlocking the full therapeutic potential of the plant and its isolated chemical constituents, facilitating their integration into mainstream clinical practice. The imperative for sustained research and inquiry into Cuscuta reflexa's medicinal properties is underscored, emphasizing the need for continued exploration to realize its therapeutic promise fully. By delving deeper into the intricacies of its pharmacological profile, we can aspire to leverage Cuscuta reflexa's medicinal virtues more effectively, thereby advancing the frontiers of medical science and enhancing healthcare outcomes for diverse populations.
- 26 August 2025
- Published by FABAD Farmasotik Bilimler Ankara Dernegi in Fabad Journal of Pharmaceutical Sciences
- Vol. 50 (2) , 447-480
A Comprehensive Review on The Phytochemical Profile, Ethnobotanical Uses and Pharmacological Activities of Cuscuta Reflexa Roxb.: An Asiatic Parasitic Vine
Cuscuta reflexa Roxb., commonly called dodder, represents a distinctive parasitic plant within the Convolvulaceae family, notable for its remarkable absence of roots and leaves. Beyond its botanical peculiarities, Cuscuta reflexa holds significant medicinal value, featuring prominently in numerous therapeutic formulations esteemed for their efficacy in addressing a diverse spectrum of ailments, including migraines, headaches, constipation, chronic catarrh, epilepsy, prolonged fever, amnesia, and itching, among others. This review endeavors to present a comprehensive synthesis of the botanical, taxonomical, pharmacological, and phytochemical attributes of Cuscuta reflexa. Employing a meticulous literature survey encompassing research articles published between 2010 and 2024, sourced from electronic databases the medicinal potential of Cuscuta reflexa emerges as multifaceted. Approximately 25 bioactive compounds have been identified and isolated from various anatomical components of the plant, showcasing significant pharmacological promise. However, despite the promising findings, a comprehensive understanding of the therapeutic mechanisms underlying Cuscuta reflexa's medicinal attributes necessitates further in vivo pharmacological and toxicological investigations. These endeavors are indispensable for unlocking the full therapeutic potential of the plant and its isolated chemical constituents, facilitating their integration into mainstream clinical practice. The imperative for sustained research and inquiry into Cuscuta reflexa's medicinal properties is underscored, emphasizing the need for continued exploration to realize its therapeutic promise fully. By delving deeper into the intricacies of its pharmacological profile, we can aspire to leverage Cuscuta reflexa's medicinal virtues more effectively, thereby advancing the frontiers of medical science and enhancing healthcare outcomes for diverse populations.